Page last updated: 2024-10-31

metyrapone and Deficiency Diseases

metyrapone has been researched along with Deficiency Diseases in 1 studies

Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.

Deficiency Diseases: A condition produced by dietary or metabolic deficiency. The term includes all diseases caused by an insufficient supply of essential nutrients, i.e., protein (or amino acids), vitamins, and minerals. It also includes an inadequacy of calories. (From Dorland, 27th ed; Stedman, 25th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sandstead, HH1
Prasad, AS1
Schulert, AR1
Farid, Z1
Miale, A1
Bassilly, S1
Darby, WJ1

Other Studies

1 other study available for metyrapone and Deficiency Diseases

ArticleYear
Human zinc deficiency, endocrine manifestations and response to treatment.
    The American journal of clinical nutrition, 1967, Volume: 20, Issue:5

    Topics: 17-Hydroxycorticosteroids; Adolescent; Adrenal Cortex Hormones; Adult; Anemia, Hypochromic; Child; D

1967